This is the PrivCo Investor Profile for Burrill & Company
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor Burrill & Company.
To unlock all information in this profile: Upgrade to PrivCo Premium

Burrill & Company

What's included with your PrivCo Premium Subscription:
Next Actions on Burrill & Company:
View Deal ActivityView Direct E-mail Contacts

Investor Summary

Burrill & Company is a San Francisco, California-based venture capital firm. Founded in 1997, Burrill & Company considers seed, early stage, late stage and mezzanine investments, as well as buyouts, acquisitions, restructurings, special situations, PIPE transactions and secondary purchases.

Investor Overview

Basic Information

Investor Type:Venture Capital
Year Founded:1997
Address:One Embarcadero Center
Suite 2700
City:San Francisco
State/Province:California
Country:United States
Phone:View
Fax:View
Website:www.burrillandco.com

Investment Preferences

Preferred Stage:Seed
Early Stage
Late Stage / Mezzanine
Buyouts / Acquisitions
Restructuring / Special Situations
PIPE
Secondary Purchases
Mid Stage / Expansion

Investor Contacts

Below are direct e-mail contacts for senior professionals at Burrill & Company.
Full contact details are available with a PrivCo Premium Subscription.
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
NameTitle
Michael KeyoungManaging Director, Burrill Pan-Asia
Bryant E. FongManaging Director
John E. HamerManaging Director
Hal GerberManaging Director
Marietta WuDirector

Private Deal History

This table is intended to portray Burrill & Company PrivCo-covered market activity. Click below for Deal Details and Private Company Reports.
All data before 2006 is completely free to view! To access data from 2006 onward:
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateTargetTarget IndustryDeal TypeTotal Deal AmountStatus
May. 2013ViewPharmaceuticalsMinority Stake PurchaseViewCompletedDetails
Feb. 2013ViewDrug Delivery TechnologyFundingViewCompletedDetails
Feb. 2013ViewContract Software DevelopmentFundingViewCompletedDetails
Feb. 2013ViewContract Software DevelopmentSecondary SaleViewCompletedDetails
Nov. 2012ViewBiotherapeuticsFundingViewCompletedDetails
Aug. 2012ViewPharmaceutical & Drug ManufacturingFundingViewCompletedDetails
Jun. 2012ViewHealth Information Technology
Mobile Applications		FundingViewCompletedDetails
Jun. 2012ViewPharmaceuticalsFundingViewCompletedDetails
Apr. 2012ViewOther Medical Devices & EquipmentFundingViewCompletedDetails
Apr. 2012ViewHealth Care Providers & Related Medical ServicesFundingViewCompletedDetails
Mar. 2012ViewBiochemicalsFundingViewCompletedDetails
Nov. 2011ViewBiochemicals
Pharmaceuticals		AcquisitionViewCompletedDetails
Aug. 2011ViewHealth Information Technology
Mobile Applications		FundingViewCompletedDetails
Aug. 2011ViewBiopharmaceuticals
Pharmaceuticals		FundingViewCompletedDetails
Aug. 2011ViewPharmaceuticalsFundingViewCompletedDetails
May. 2011ViewBiofuel Refinery
Other Biofuels		FundingViewCompletedDetails
Sep. 2010ViewPharmaceuticalsFundingViewCompletedDetails
Sep. 2010ViewBiotherapeuticsFundingViewCompletedDetails
Jul. 2010ViewBiotherapeuticsFundingViewCompletedDetails
Jun. 2010ViewHealth & Medical SoftwareFundingViewCompletedDetails
Jun. 2010ViewOther Clinical Research ServicesFundingViewCompletedDetails
May. 2010ViewBiopharmaceuticals
Drug Delivery Technology		FundingViewCompletedDetails
May. 2010ViewBiochemicals
Biofuel Refinery
Biotechnology
Ethanol		FundingViewCompletedDetails
Mar. 2010ViewDrug Delivery TechnologyFundingViewCompletedDetails
Jan. 2010ViewOther BiofuelsFundingViewCompletedDetails
Dec. 2009ViewBiotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Oct. 2009ViewBiochemicals
Biotechnology		FundingViewCompletedDetails
Sep. 2009ViewBiotechnology
Medical Diagnostic Equipment		FundingViewCompletedDetails
Aug. 2009ViewBiotechnologyFundingViewCompletedDetails
May. 2009ViewDrug Delivery Technology
Pharmaceuticals		FundingViewCompletedDetails
May. 2009ViewBiochemicalsFundingViewCompletedDetails
Mar. 2009ViewOther Healthcare
Supplementary Medicine & Nutrition		FundingViewCompletedDetails
Dec. 2008ViewBiopharmaceuticals
Drug Delivery Technology		FundingViewCompletedDetails
Dec. 2008ViewDrug Delivery TechnologyFundingViewCompletedDetails
Nov. 2008ViewDrug Delivery TechnologyFundingViewCompletedDetails
Nov. 2008ViewOther Clinical Research ServicesFundingViewCompletedDetails
Nov. 2008ViewGenomics And Molecular AnalysisFundingViewCompletedDetails
Oct. 2008ViewDrug-Related ProductsFundingViewCompletedDetails
Oct. 2008ViewDrug Delivery TechnologyFundingViewCompletedDetails
Sep. 2008ViewMedical Diagnostic TechnologyFundingViewCompletedDetails
Sep. 2008ViewDrug Delivery Technology
Pharmaceuticals		FundingViewCompletedDetails
Aug. 2008ViewDrug Delivery TechnologyFundingViewCompletedDetails
Aug. 2008ViewManaged Health Care Plans
Veterinary Pharmaceuticals		FundingViewCompletedDetails
May. 2008ViewBiochemicals
Biofuel Refinery
Biotechnology
Ethanol		FundingViewCompletedDetails
May. 2008ViewDrug Delivery Technology
Pharmaceuticals		FundingViewCompletedDetails
Mar. 2008ViewMedical Device Design & ManufacturingFundingViewCompletedDetails
Mar. 2008ViewBiopharmaceuticalsFundingViewCompletedDetails
Jan. 2008ViewBiotechnology
Medical Diagnostic Equipment		FundingViewCompletedDetails
Dec. 2007ViewDrug Delivery TechnologyFundingViewCompletedDetails
Jul. 2007ViewMedical Devices & EquipmentFundingViewCompletedDetails
Jan. 2007ViewAcquisition
Joint Venture / Partnership Formed		ViewCompletedDetails
Jan. 2007ViewBiochemicalsFundingViewCompletedDetails
Nov. 2006ViewBiotherapeutics
Pharmaceuticals		FundingViewCompletedDetails
Aug. 2006ViewOther Healthcare
Supplementary Medicine & Nutrition		FundingViewCompletedDetails
Jul. 2006ViewBiochemicalsAcquisitionViewCompletedDetails
Apr. 2006ViewMedical Diagnostic TechnologyAcquisitionViewCompletedDetails
Apr. 2006ViewBiotechnologyFundingViewCompletedDetails
Feb. 2006ViewDrug Delivery TechnologyFundingViewCompletedDetails
Jan. 2006ViewBiotechnologyFundingViewCompletedDetails
Jan. 2006ViewBiotechnologyFundingViewCompletedDetails
Aug. 2005ChlorogenBiotechnologyFunding$6,000,000CompletedDetails
Oct. 2004Catalyst BiosciencesDrug Delivery TechnologyFunding$10,300,000CompletedDetails
Oct. 2002AgraQuest, Inc.Ag-Biotech (Green Biotechnology)Funding$8,221,000CompletedDetails
Mar. 2002Odyssey Thera, Inc.Drug Delivery TechnologyFunding$15,000,000CompletedDetails
Dec. 2000AgraQuest, Inc.Ag-Biotech (Green Biotechnology)Funding$15,000,000CompletedDetails
Mar. 2000Odyssey Thera, Inc.Drug Delivery TechnologyFunding$3,000,000CompletedDetails
Jul. 1999AgraQuest, Inc.Ag-Biotech (Green Biotechnology)Funding$7,000,000CompletedDetails

Supplemental Resources

For additional information on Burrill & Company, or on private company investing, you can see the following:
What's included with your PrivCo Premium Subscription:
Next Actions on Burrill & Company:
View Deal ActivityView Direct E-mail Contacts
  • Learn More About PrivCo
  • PrivCo’s Clients Include:
  • Clients Include: Motorola, 3M, Samsung, Oracle, TATA, Johnson and Johnson, CB Richard Ellis
  • PrivCo Is Featured In:
  • Featured In: The New York Times, New York Post, Bloomberg, CNBC, NPR, The Washington Post, The Wall Street Journal, CNN, Fortune, BusinessWeek, Reuters, CBS News, USA Today
PrivCo’s 300-page Private Company Tech M&A Report for 2012 - Click Here For Full Report
  • Quick Investor Search

within miles
Go to Advanced Search
  • What is PrivCo?

PrivCo is the authority for financial & business data on major private market investors, including:

PrivCo Private Deals Newsletter.
It's FREE!

This is the PrivCo Investor Profile for Burrill & Company
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor Burrill & Company.
To unlock all information in this profile: Upgrade to PrivCo Premium